文献速递心境障碍会诊联络精神医学

免疫介导疾病与重性抑郁障碍的双向关联:队列、全基因组多效性与实验研究

Bidirectional association between immune-mediated diseases and major depressive disorder: evidence from cohort, genome-wide pleiotropic, and experimental studies.
PubMed 文献 · Mol Psychiatry · 2026-02-04

基于英国生物银行前瞻队列,免疫介导疾病(IMD)与重性抑郁障碍(MDD)存在双向关联:IMD患者MDD风险升高(HR 1.95),MDD患者IMD风险亦升高(HR 1.47)。全基因组分析显示两者存在显著遗传相关(rg 0.11-0.49)并识别128个多效性基因。小鼠实验支持类风湿关节炎与抑郁样行为双向加重,涉及炎症与神经营养因子失调通路。

要点

  • IMD患者发生MDD的风险显著升高(HR 1.95;95% CI 1.89-2.01)。
  • MDD患者发生IMD的风险亦升高(HR 1.47;95% CI 1.40-1.54)。
  • IMD与MDD存在共享遗传易感性及免疫-神经生物学通路。

核心结论

  • 人群、遗传和实验证据共同支持免疫介导疾病与重性抑郁障碍之间存在双向关联和共享遗传易感性。
  • 免疫-神经生物学通路,尤其涉及炎症和神经营养因子失调,是机制解析和治疗靶点的候选方向。

研究设计与样本

  • 前瞻性UK Biobank队列研究,采用时变Cox比例风险回归模型评估双向关联。
  • 利用全基因组关联研究汇总统计量评估共享遗传结构。
  • 采用胶原诱导性关节炎(CIA)和慢性社会挫败应激(CSDS)小鼠模型探究类风湿关节炎与抑郁的关系。

主要发现

  • 随访超过5,226,841人年,识别23,534例新发MDD;任何IMD与MDD风险升高相关(HR 1.95;95% CI 1.89-2.01)。
  • 记录59,742例新发IMD;MDD与IMD风险升高相关(HR 1.47;95% CI 1.40-1.54)。
  • IMD与MDD存在显著全局遗传相关(rg 0.11-0.49),识别128个多效性基因,包括ZKSCAN4、BTN3A2和HSPA1L。
  • 临床上类风湿关节炎患者表现全身炎症和脑源性神经营养因子水平降低。
  • CIA小鼠表现抑郁样行为和抑郁相关脑区病变;CSDS叠加CIA加重抑郁样行为和痛敏,加速关节炎发病和进展,并加剧关节炎症。

关键数值与推荐

  • IMD与MDD双向关联的效应量:IMD→MDD HR 1.95(95% CI 1.89-2.01);MDD→IMD HR 1.47(95% CI 1.40-1.54)。
  • IMD与MDD全局遗传相关rg范围为0.11-0.49,识别128个多效性基因。

临床怎么用

  • 对免疫介导疾病患者应关注抑郁症状筛查,对MDD患者也应关注免疫介导疾病风险。
  • 类风湿关节炎患者可考虑监测全身炎症和脑源性神经营养因子水平。
  • 炎症和神经营养因子失调通路可能为跨诊断干预提供靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although immune-mediated diseases (IMDs) and major depressive disorder (MDD) commonly co-occur, the bidirectional relationship between them remains to be fully elucidated. Using data from the prospective UK Biobank cohort, we evaluated the bidirectional associations by time-varying Cox proportional hazards regression models and assessed shared genetic architecture using genome-wide association study summary statistics. Additionally, we employed collagen-induced arthritis (CIA) and chronic social defeat stress (CSDS) mouse models to investigate the relationship between rheumatoid arthritis (RA) and depression. Over 5,226,841 person-years of follow-up, 23,534 incident MDD cases were identified. The presence of any IMD was associated with higher MDD risk (hazard ratio [HR]: 1.95; 95% CI: 1.89-2.01). Conversely, 59,742 incident cases of IMD were documented. MDD was associated with increased IMD risk (HR: 1.47; 95% CI: 1.40-1.54). We observed significant global genetic correlations between IMDs and MDD (rg: 0.11-0.49) and identified 128 pleiotropic genes, including ZKSCAN4, BTN3A2, and HSPA1L. Clinically, RA patients exhibited systemic inflammation and decreased levels of brain-derived neurotrophic factor. In experimental models, CIA mice showed depressive-like behaviors and lesions in brain regions implicated in depression. Moreover, superimposing CSDS on CIA exacerbated depressive-like behavior and pain sensitivity, accelerated the onset and progression of arthritis, and heightened joint inflammation. Collectively, these population, genetic, and experimental findings support a bidirectional association and shared genetic susceptibility between IMDs and MDD, highlighting immune-neurobiological pathways, particularly those involving inflammation and neurotrophin dysregulation, as candidates for mechanistic dissection and therapeutic targets.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Chen X, Liu H, Liu Y, et al. Bidirectional association between immune-mediated diseases and major depressive disorder: evidence from cohort, genome-wide pleiotropic, and experimental studies. Mol Psychiatry. 2026. PMID: 41639228. doi:10.1038/s41380-026-03459-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。